ePRO, 전자 환자 일지, eCOA 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global ePRO, E-patient Diaries, and eCOA Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, opportunities, and challenges. This detailed report offers critical insights into the market landscape, supporting strategic decision-making for stakeholders.

Key Insights:

• ePRO, E-patient Diaries, and eCOA Market Size (2024E): USD 18.2 Bn
• Projected Market Value (2031F): USD 50.5 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 15.7%

ePRO, E-patient Diaries, and eCOA Market - Report Scope:

The ePRO, e-patient diaries, and eCOA market encompass electronic tools that allow patients to report clinical outcomes in real-time, facilitating data collection for clinical trials and healthcare studies. These technologies enable efficient capture of patient-reported outcomes (PROs), adverse event data, and other health outcomes, improving trial data quality and patient engagement. The market is fueled by rising demand for remote healthcare solutions, technological advancements in eCOA systems, and the growing adoption of digital health applications within clinical trials.

Market Growth Drivers:

Key factors driving the global ePRO, E-patient Diaries, and eCOA market include increased clinical trial activity, the growing demand for patient-centric data collection, and a shift towards digital health. Regulatory agencies increasingly recognize ePRO and eCOA as reliable sources for real-world evidence, further boosting market adoption. Additionally, advancements in mobile health technology, wearables, and remote patient monitoring systems support growth by providing more efficient and accurate data collection tools. The rising focus on reducing trial costs and increasing patient engagement in studies also contributes to market expansion.

Market Restraints:

Despite strong growth potential, the market faces challenges, including concerns around data security, privacy, and regulatory compliance. The high cost of implementing and maintaining ePRO and eCOA systems may deter small and mid-sized clinical research organizations from adoption. Additionally, there is variability in regulatory requirements across regions, which may hinder uniform deployment of these technologies. Limited technological literacy among certain patient populations and inconsistent internet access may also impact data collection quality and restrict adoption.

Market Opportunities:

The ePRO, e-patient diaries, and eCOA market present substantial opportunities due to the growing emphasis on decentralized clinical trials and remote patient monitoring. Development of user-friendly platforms and integration with wearable health devices and telehealth systems provide new avenues for growth. Expanding applications in emerging markets and increased acceptance of real-world data by regulatory authorities enhance market opportunities. Strategic partnerships with healthcare providers, pharma companies, and technology firms can further boost market presence and enable new product innovations.

Key Questions Answered in the Report:

• What are the main factors driving the global growth of the ePRO, e-patient diaries, and eCOA market?
• Which regions are witnessing the highest adoption of eCOA technologies, and why?
• How are technological advancements influencing the competitive landscape in this market?
• Who are the key players in the ePRO and eCOA market, and what strategies are they employing to maintain market position?
• What are the emerging trends and future outlooks for the ePRO, e-patient diaries, and eCOA market?

Competitive Intelligence and Business Strategy:

Leading players in the ePRO, E-patient Diaries, and eCOA market, such as Medidata Solutions, CRF Health, and Signant Health, are prioritizing innovation, user-friendly technology, and data security to maintain a competitive edge. These companies invest in advanced eCOA platforms that integrate with mobile devices, wearables, and cloud solutions to ensure seamless data collection. Collaborations with pharmaceutical companies, regulatory bodies, and clinical research organizations are vital for expanding market reach and securing regulatory approvals. Focus on compliance, user engagement, and data accuracy are core strategies for long-term success in this evolving market.

Key Companies Profiled:

• Medidata Solutions
• CRF Health
• Signant Health
• Bracket Global
• ArisGlobal LLC
• Parexel International Corporation
• ERT Clinical
• ICON plc
• OmniComm Systems
• BioClinica
• Kayentis
• Medable Inc.

ePRO, E-patient Diaries, and eCOA Industry Research by Category:

By Type of Solution:

• eCOA (Electronic Clinical Outcome Assessments)
• ePROs (Patient Reported Outcomes)
• ClinROs (Clinician Reported Outcomes)
• ObsROs (Observer Reported Outcomes)
• PerfOs (Performance Outcomes)
• E-Patient Diaries

By End User:

• Clinical Trial Sponsors
• Contract Research Organizations (CROs)
• Hospitals
• Academic Institutes
• Pharmaceutical Companies
• Medical Device Manufacturers

By Modality Type:

• Computer
• Mobile Devices (Smartphones and Tablets)

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. PMR Analysis and Recommendations
• 1.3. Wheel of Fortune

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy
• 2.3. Value Chain Analysis

3. Market Viewpoint

• 3.1. Macro-Economic Factors
• 3.2. Opportunity Analysis
• 3.3. Market Snapshot
• 3.4. Global Standards & Regulations

4. North America ePRO, E-Patient Diaries and eCOA Market Analysis and Forecast

• 4.1. Introduction
• 4.2. Regional Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Trends
• 4.3. Drivers and Restraints: Impact Analysis
• 4.4. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Country
  • 4.4.1. U.S.
  • 4.4.2. Canada
• 4.5. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 & Forecast 2024-2031 By Type of Solution
  • 4.5.1. eCOA
    • 4.5.1.1. ePROs (Patient Reported Outcomes)
    • 4.5.1.2. ClinROs (Clinician Reported Outcomes)
    • 4.5.1.3. ObsROs (Observer reported Outcomes)
    • 4.5.1.4. PerfOs (Performance Outcomes)
  • 4.5.2. E-Patient Diaries
• 4.6. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Modality Type
  • 4.6.1. Computer
  • 4.6.2. Mobile Devices (Smartphones & Tablets)
• 4.7. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By End-user
  • 4.7.1. Clinical Trial Sponsors
  • 4.7.2. Contract Research Organizations (CROs)
  • 4.7.3. Hospitals
  • 4.7.4. Academic Institutes
  • 4.7.5. Pharmaceutical Companies
  • 4.7.6. Medical Device Manufacturers
• 4.8. Market Attractiveness Analysis
  • 4.8.1. By Country
  • 4.8.2. By Type of Solution
  • 4.8.3. By Modality Type
  • 4.8.4. By End-user
• 4.9. Market Presence (Intensity Map)

5. Latin America ePRO, E-Patient Diaries and eCOA Market Analysis and Forecast

• 5.1. Introduction
• 5.2. Regional Market Dynamics
  • 5.2.1. Drivers
  • 5.2.2. Restraints
  • 5.2.3. Trends
• 5.3. Drivers and Restraints: Impact Analysis
• 5.4. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Country
  • 5.4.1. Brazil
  • 5.4.2. Mexico
  • 5.4.3. Argentina
  • 5.4.4. Rest of Latin America
• 5.5. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 & Forecast 2024-2031 By Type of Solution
  • 5.5.1. eCOA
    • 5.5.1.1. ePROs (Patient Reported Outcomes)
    • 5.5.1.2. ClinROs (Clinician Reported Outcomes)
    • 5.5.1.3. ObsROs (Observer reported Outcomes)
    • 5.5.1.4. PerfOs (Performance Outcomes)
  • 5.5.2. E-Patient Diaries
• 5.6. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Modality Type
  • 5.6.1. Computer
  • 5.6.2. Mobile Devices (Smartphones & Tablets)
• 5.7. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By End-user
  • 5.7.1. Clinical Trial Sponsors
  • 5.7.2. Contract Research Organizations (CROs)
  • 5.7.3. Hospitals
  • 5.7.4. Academic Institutes
  • 5.7.5. Pharmaceutical Companies
  • 5.7.6. Medical Device Manufacturers
• 5.8. Market Attractiveness Analysis
  • 5.8.1. By Country
  • 5.8.2. By Type of Solution
  • 5.8.3. By Modality Type
  • 5.8.4. By End-user
• 5.9. Market Presence (Intensity Map)

6. Europe ePRO, E-Patient Diaries and eCOA Market Analysis and Forecast

• 6.1. Introduction
• 6.2. Regional Market Dynamics
  • 6.2.1. Drivers
  • 6.2.2. Restraints
  • 6.2.3. Trends
• 6.3. Drivers and Restraints: Impact Analysis
• 6.4. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Country
  • 6.4.1. Germany
  • 6.4.2. U.K.
  • 6.4.3. France
  • 6.4.4. Spain
  • 6.4.5. Italy
  • 6.4.6. Poland
  • 6.4.7. Russia
  • 6.4.8. Rest of Europe
• 6.5. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 & Forecast 2024-2031 By Type of Solution
  • 6.5.1. eCOA
    • 6.5.1.1. ePROs (Patient Reported Outcomes)
    • 6.5.1.2. ClinROs (Clinician Reported Outcomes)
    • 6.5.1.3. ObsROs (Observer reported Outcomes)
    • 6.5.1.4. PerfOs (Performance Outcomes)
  • 6.5.2. E-Patient Diaries
• 6.6. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Modality Type
  • 6.6.1. Computer
  • 6.6.2. Mobile Devices (Smartphones & Tablets)
• 6.7. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By End-user
  • 6.7.1. Clinical Trial Sponsors
  • 6.7.2. Contract Research Organizations (CROs)
  • 6.7.3. Hospitals
  • 6.7.4. Academic Institutes
  • 6.7.5. Pharmaceutical Companies
  • 6.7.6. Medical Device Manufacturers
• 6.8. Market Attractiveness Analysis
  • 6.8.1. By Country
  • 6.8.2. By Type of Solution
  • 6.8.3. By Modality Type
  • 6.8.4. By End-user
• 6.9. Market Presence (Intensity Map)

7. Asia Pacific ePRO, E-Patient Diaries and eCOA Market Analysis and Forecast

• 7.1. Introduction
• 7.2. Regional Market Dynamics
  • 7.2.1. Drivers
  • 7.2.2. Restraints
  • 7.2.3. Trends
• 7.3. Drivers and Restraints: Impact Analysis
• 7.4. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Country
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. India
  • 7.4.4. ASEAN
  • 7.4.5. Australia and New Zealand
  • 7.4.6. Rest of Asia Pacific
• 7.5. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 & Forecast 2024-2031 By Type of Solution
  • 7.5.1. eCOA
    • 7.5.1.1. ePROs (Patient Reported Outcomes)
    • 7.5.1.2. ClinROs (Clinician Reported Outcomes)
    • 7.5.1.3. ObsROs (Observer reported Outcomes)
    • 7.5.1.4. PerfOs (Performance Outcomes)
  • 7.5.2. E-Patient Diaries
• 7.6. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Modality Type
  • 7.6.1. Computer
  • 7.6.2. Mobile Devices (Smartphones & Tablets)
• 7.7. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By End-user
  • 7.7.1. Clinical Trial Sponsors
  • 7.7.2. Contract Research Organizations (CROs)
  • 7.7.3. Hospitals
  • 7.7.4. Academic Institutes
  • 7.7.5. Pharmaceutical Companies
  • 7.7.6. Medical Device Manufacturers
• 7.8. Market Attractiveness Analysis
  • 7.8.1. By Country
  • 7.8.2. By Type of Solution
  • 7.8.3. By Modality Type
  • 7.8.4. By End-user
• 7.9. Market Presence (Intensity Map)

8. Middle East and Africa ePRO, E-Patient Diaries and eCOA Market Analysis & Forecast

• 8.1. Introduction
• 8.2. Regional Market Dynamics
  • 8.2.1. Drivers
  • 8.2.2. Restraints
  • 8.2.3. Trends
• 8.3. Drivers and Restraints: Impact Analysis
• 8.4. Historic & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Country
  • 8.4.1. GCC Countries
  • 8.4.2. North Africa
  • 8.4.3. South Africa
  • 8.4.4. Turkey
  • 8.4.5. Rest of Middle East and Africa
• 8.5. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 & Forecast 2024-2031 By Type of Solution
  • 8.5.1. eCOA
    • 8.5.1.1. ePROs (Patient Reported Outcomes)
    • 8.5.1.2. ClinROs (Clinician Reported Outcomes)
    • 8.5.1.3. ObsROs (Observer reported Outcomes)
    • 8.5.1.4. PerfOs (Performance Outcomes)
  • 8.5.2. E-Patient Diaries
• 8.6. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Modality Type
  • 8.6.1. Computer
  • 8.6.2. Mobile Devices (Smartphones & Tablets)
• 8.7. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By End-user
  • 8.7.1. Clinical Trial Sponsors
  • 8.7.2. Contract Research Organizations (CROs)
  • 8.7.3. Hospitals
  • 8.7.4. Academic Institutes
  • 8.7.5. Pharmaceutical Companies
  • 8.7.6. Medical Device Manufacturers
• 8.8. Market Attractiveness Analysis
  • 8.8.1. By Country
  • 8.8.2. By Type of Solution
  • 8.8.3. By Modality Type
  • 8.8.4. By End-user
• 8.9. Market Presence (Intensity Map)

9. Forecast Factors & Assumptions

10. Competition Landscape

• 10.1. Market Structure
• 10.2. Market Share Analysis
• 10.3. Competition Dashboard
• 10.4. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 10.4.1. Bracket Global LLC
  • 10.4.2. CRF Health, Inc.
  • 10.4.3. ERT Clinical
  • 10.4.4. Medidata Solutions, Inc.
  • 10.4.5. ArisGlobal LLC
  • 10.4.6. Health Diary, Inc.
  • 10.4.7. ICON plc
  • 10.4.8. PAREXEL International Corporation
  • 10.4.9. OmniComm Systems, Inc.
  • 10.4.10. Kayentis, SAS

11. Global EPRO, E-Patient Diaries and eCOA Market Analysis & Forecast, By Region

• 11.1. Introduction
• 11.2. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Region
  • 11.2.1. North America
  • 11.2.2. Latin America
  • 11.2.3. Europe
  • 11.2.4. Asia Pacific
  • 11.2.5. Middle East and Africa
• 11.3. Market Attractiveness Analysis By Region

12. Global ePRO, E-Patient Diaries and eCOA Market Analysis & Forecast, By Type of Solution

• 12.1. Introduction
• 12.2. Historical & Current Market Size (US$ Bn) Analysis 2019-2023 & Forecast 2024-2031, By Type of Solution
  • 12.2.1. eCOA
    • 12.2.1.1. ePROs (Patient Reported Outcomes)
    • 12.2.1.2. ClinROs (Clinician Reported Outcomes)
    • 12.2.1.3. ObsROs (Observer reported Outcomes)
    • 12.2.1.4. PerfOs (Performance Outcomes)
  • 12.2.2. E-Patient Diaries
• 12.3. Market Attractiveness Analysis By Type of Solution

13. Global ePRO, E-Patient Diaries and eCOA Market Analysis & Forecast, By Modality Type

• 13.1. Introduction
• 13.2. Historic & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By Modality Type
  • 13.2.1. Computer
  • 13.2.2. Mobile Devices (Smartphones & Tablets)
• 13.3. Market Attractiveness Analysis By Modality Type

14. Global EPRO, E-Patient Diaries and eCOA Market Analysis & Forecast, By End-user

• 14.1. Introduction
• 14.2. Historic & Current Market Size (US$ Bn) Analysis 2019-2023 and Forecast 2024-2031, By End-user
  • 14.2.1. Clinical Trial Sponsors
  • 14.2.2. Contract Research Organizations (CROs)
  • 14.2.3. Hospitals
  • 14.2.4. Academic Institutes
  • 14.2.5. Pharmaceutical Companies
  • 14.2.6. Medical Device Manufacturers
• 14.3. Market Attractiveness Analysis By End-user

15. Assumptions and Acronyms Used

16. Research Methodology